ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 89 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,107 | -89.1% | 13,068 | -85.1% | 0.00% | – |
| Q2 2023 | $313,261 | +912.7% | 87,503 | +516.7% | 0.00% | – |
| Q1 2023 | $30,932 | -99.4% | 14,189 | -96.9% | 0.00% | -100.0% |
| Q4 2022 | $5,434,023 | +226.2% | 451,706 | +75.6% | 0.00% | – |
| Q3 2022 | $1,666,000 | +109.0% | 257,237 | +47.8% | 0.00% | – |
| Q2 2022 | $797,000 | -56.4% | 174,038 | -17.6% | 0.00% | – |
| Q1 2022 | $1,828,000 | -77.2% | 211,285 | -62.4% | 0.00% | – |
| Q4 2021 | $8,034,000 | +36.2% | 562,616 | +109.7% | 0.00% | -100.0% |
| Q3 2021 | $5,898,000 | +312.4% | 268,332 | +151.0% | 0.00% | – |
| Q2 2021 | $1,430,000 | -12.5% | 106,902 | -33.5% | 0.00% | – |
| Q1 2021 | $1,634,000 | +553.6% | 160,805 | +173.5% | 0.00% | – |
| Q4 2020 | $250,000 | +309.8% | 58,800 | +151.3% | 0.00% | – |
| Q3 2020 | $61,000 | -63.9% | 23,400 | -51.0% | 0.00% | – |
| Q2 2020 | $169,000 | +2.4% | 47,800 | -12.0% | 0.00% | – |
| Q1 2020 | $165,000 | -57.7% | 54,300 | -28.3% | 0.00% | – |
| Q4 2019 | $390,000 | +729.8% | 75,728 | +411.5% | 0.00% | – |
| Q3 2019 | $47,000 | -71.7% | 14,804 | -19.9% | 0.00% | – |
| Q4 2017 | $166,000 | -10.3% | 18,474 | -1.5% | 0.00% | – |
| Q3 2017 | $185,000 | -65.3% | 18,762 | -74.4% | 0.00% | – |
| Q3 2016 | $533,000 | -47.0% | 73,400 | -39.0% | 0.00% | – |
| Q2 2016 | $1,005,000 | +151.9% | 120,400 | +100.7% | 0.00% | – |
| Q1 2016 | $399,000 | -20.5% | 60,000 | +2.2% | 0.00% | – |
| Q4 2015 | $502,000 | +164.2% | 58,700 | +69.3% | 0.00% | – |
| Q3 2015 | $190,000 | -36.2% | 34,672 | -34.0% | 0.00% | – |
| Q2 2015 | $298,000 | +238.6% | 52,500 | +280.4% | 0.00% | – |
| Q1 2015 | $88,000 | -50.3% | 13,800 | -64.5% | 0.00% | – |
| Q4 2014 | $177,000 | -42.0% | 38,868 | +2.7% | 0.00% | – |
| Q3 2014 | $305,000 | -66.0% | 37,839 | -59.4% | 0.00% | – |
| Q2 2014 | $897,000 | +218.1% | 93,279 | +284.2% | 0.00% | – |
| Q1 2014 | $282,000 | – | 24,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
| Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
| Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
| Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
| XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
| Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
| Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
| ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
| Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |